bioMérieux

Equities

BIM

FR0013280286

Market Closed - Euronext Paris Other stock markets 16:55:00 15/05/2026 BST			After hours 18:24:57
71.65 ^EUR	-1.10%		71.65	0.00%

05-07	The Rally Spreads
05-06	L'Institut Merieux: bought an extra 1% in Biomérieux, bringing its total stake in company to around 60%	RE

Transcript : BioMérieux S.A., Q1 2022 Earnings Call, Apr 27, 2022

Published on 04/26/2022

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good day, and welcome to the bioMérieux First Quarter 2022 Sales Results Conference Call. Today's conference is being recorded. And now at this time, I

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about bioMérieux

05-07	The Rally Spreads
05-06	L'Institut Merieux: bought an extra 1% in Biomérieux, bringing its total stake in company to around 60%	RE
04-24	Deutsche Bank Downgrades bioMérieux to Hold, Cuts PT	MT
04-23	BioMerieux: Disappointing Q1 and lower guidance undermine investor confidence
04-23	BioMérieux S.A., Q1 2026 Sales/ Trading Statement Call, Apr 23, 2026
04-23	BioMérieux tumbles on lowered annual guidance
04-23	Biomerieux Q1 sales EUR 984 million	RE
04-22	Carrefour, L'Oréal, EssilorLuxottica... stocks to watch tomorrow in Paris
04-20	BioMérieux S.A.Announces Multi-Country Health Economic Analysis Assessing Impact of Deploying Fast Identification and Antimicrobial Susceptibility Testing Early in Care Pathway for Patients with Bloodstream Infections At High-Risk of Sepsis	CI
04-13	RBC Capital Favors Diasorin Over bioMérieux
04-10	AlphaValue Urges Patience on bioMérieux, Maintains Buy Rating
04-09	BioMérieux Unveils Biofire Spotfire Molecular Testing Solution For The Pharmaceutical Industry	CI
04-09	JCDecaux, OVHcloud, Fleury Michon... Stocks to watch today in Paris
04-09	BioMérieux launches Biofire Spotfire for the pharmaceutical industry
03-19	CE IVDR marking for two bioMérieux Biofire Spotfire tests